Kardiomiopatia połogowa – aktualny stan wiedzy Artykuł przeglądowy

##plugins.themes.bootstrap3.article.main##

Olga Możeńska
Irena Kalińska
Dariusz A. Kosior

Abstrakt

Kardiomiopatia połogowa, zwana inaczej kardiomiopatią w czasie połogu, jest jedną z rzadkich przyczyn niewydolności serca występującą u kobiet pod koniec ciąży lub we wczesnym okresie połogu. W artykule opisano aktualny stan wiedzy na temat kardiomiopatii połogowej, jej epidemiologię, etiologię, czynniki ryzyka, obraz kliniczny, metody rozpoznawania, leczenia i rokowanie.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.themes.bootstrap3.article.details##

Jak cytować
Możeńska , O., Kalińska , I., & Kosior , D. A. (2013). Kardiomiopatia połogowa – aktualny stan wiedzy . Kardiologia W Praktyce, 7(3), 10-21. Pobrano z https://journalsmededu.pl/index.php/kwp/article/view/1559
Dział
Artykuły

Bibliografia

1. Richie C.: Clinical contribution to the pathology, diagnosis and treatment of certain chronic diseases of the heart. Edinb. Med. Surg. J. 1849, 2: 333.
2. Hull E., Hafkesbring E.: Toxic postpartal heart disease. New Orleans Med. Surg. J. 1937, 89: 550.
3. Sliwa K., Fett J., Elkayam U.: Peripartum cardiomyopathy. Lancet 2006, 368(9536): 687-693.
4. Demakis J.G., Rahimtoola S.H., Sutton G.C., Meadows W.R., Szanto P.B., Tobin J.R., Gunnar R.M.: Natural course of peripartum cardiomyopathy. Circulation 1971, 44(6): 1053-1061.
5. Pearson G.D., Veille J.C., Rahimtoola S., Hsia J., Oakley C.M., Hosenpud J.D., Ansari A., Baughman K.L.: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000, 283(9): 1183-1188.
6. Hibbard J.U., Lindheimer M., Lang R.M.: A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstetrics and Gynecology 1999, 94(2): 311-316.
7. Elkayam U., Akhter M.W., Singh H., Khan S., Bitar F., Hameed A., Shotan A.: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111(16): 2050-2055.
8. Seftel H., Susser M.: Maternity and myocardial failure in African women. British Heart Journal 1961, 23: 43-52.
9. Davidson N.M., Parry E.H.: The etiology of peripartum cardiac failure. American Heart Journal 1979, 97(4): 535-536.
10. Woolford R.M.: Postpartum myocardosis. Ohio medicine: journal of the Ohio State Medical Association 1952, 48(10): 924-930.
11. Pierce J.A., Price B.O., Joyce J.W.: Familial occurrence of postpartal heart failure. Archives of Internal Medicine 1963, 111: 651-655.
12. Sliwa K., Damasceno A., Mayosi B.M.: Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005, 112(23): 3577-3583.
13. Lampert M.B., Lang R.M.: Peripartum cardiomyopathy. American Heart Journal 1995, 130(4): 860-870.
14. Fett J.D., Christie L.G., Carraway R.D., Murphy J.G.: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clinic proceedings Mayo Clinic 2005, 80(12): 1602-1606.
15. King T.M., Whitehorn W.V., Reeves B., Kubota R.: Effects of estrogen on composition and function of cardiac muscle. The American Journal of Physiology 1959, 196(6): 1282-1285.
16. Ueland K., Parer J.T.: Effects of estrogens on the cardiovascular system of the ewe. American Journal of Obstetrics and Gynecology 1966, 96(3): 400-406.
17. Schaible T.F., Malhotra A., Ciambrone G., Scheuer J.: The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circulation Research 1984, 54(1): 38-49.
18. Bryant E.E., Douglas B.H., Ashburn A.D.: Circulatory changes following prolactin administration. American Journal of Obstetrics and Gynecology 1973, 115(1): 53-57.
19. Sliwa K., Skudicky D., Bergemann A., Candy G., Puren A., Sareli P.: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. Journal of the American College of Cardiology 2000, 35(3): 701-705.
20. Sliwa K., Forster O., Libhaber E., Fett J.D., Sundstrom J.B., Hilfiker-Kleiner D., Ansari A.A.: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. European Heart Journal 2006, 27(4): 441-446.
21. Hilfiker-Kleiner D., Kaminski K., Podewski E., Bonda T., Schaefer A., Sliwa K., Forster O., Quint A., Landmesser U., Doerries C. et al.: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128(3): 589-600.
22. Melvin K.R., Richardson P.J., Olsen E.G., Daly K., Jackson G.: Peripartum cardiomyopathy due to myocarditis. N. Engl. J. Med. 1982, 307(12): 731-734.
23. Sanderson J.E., Olsen E.G., Gatei D.: Peripartum heart disease: an endomyocardial biopsy study. British Heart Journal 1986, 56(3): 285-291.
24. O’Connell J.B., Costanzo-Nordin M.R., Subramanian R., Robinson J.A., Wallis D.E., Scanlon P.J., Gunnar R.M.: Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. Journal of the American College of Cardiology 1986, 8(1): 52-56.
25. Midei M.G., DeMent S.H., Feldman A.M., Hutchins G.M., Baughman K.L.: Peripartum myocarditis and cardiomyopathy. Circulation 1990, 81(3): 922-928.
26. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., Kandolf R.: High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. American Journal of Obstetrics and Gynecology 2005, 193(2): 363-365.
27. Rizeq M.N., Rickenbacher P.R., Fowler M.B., Billingham M.E.: Incidence of myocarditis in peripartum cardiomyopathy. The American Journal of Cardiology 1994, 74(5): 474-477.
28. Nelson J.L.: Pregnancy, persistent microchimerism, and autoimmune disease. Journal of the American Medical Women’s Association 1998, 53(1): 31-32, 47.
29. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., Sundstrom J.B.: Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clinical Reviews in Allergy & Immunology 2002, 23(3): 301-324.
30. Cenac A., Beaufils H., Soumana I., Vetter J.M., Devillechabrolle A., Moulias R.: Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. International Journal of Cardiology 1990, 26(1): 49-52.
31. Pearl W.: Familial occurrence of peripartum cardiomyopathy. American Heart Journal 1995, 129(2): 421-422.
32. van Spaendonck-Zwarts K.Y., van Tintelen J.P., van Veldhuisen D.J., van der Werf R., Jongbloed J.D., Paulus W.J., Dooijes D., van den Berg M.P.: Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010, 121(20): 2169-2175.
33. Morales A., Painter T., Li R., Siegfried J.D., Li D., Norton N., Hershberger R.E.: Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010, 121(20): 2176-2182.
34. Murali S., Baldisseri M.R.: Peripartum cardiomyopathy. Critical Care Medicine 2005, 33(10 Suppl.): S340-346.
35. Podewski E.K., Hilfiker-Kleiner D., Hilfiker A., Morawietz H., Lichtenberg A., Wollert K.C., Drexler H.: Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 2003, 107(6): 798-802.
36. Veille J.C.: Peripartum cardiomyopathies: a review. American Journal of Obstetrics and Gynecology 1984, 148: 805.
37. Homans D.: Peripartum cardiomyopathy. N. Engl. J. Med. 1984, 312: 1432.
38. Mendelson M.: Postpartum cardiomyopathy associated with maternal cocaine abuse. The American Journal of Cardiology 1992, 70: 1092.
39. Lampert M.B., Hibbard J., Weinert L. et al.: Peripartum heart failure associated with prolonged tocolytic therapy. American Journal of Obstetrics and Gynecology 1993, 168: 493.
40. Kothari S.: Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? International Journal of Cardiology 1997, 60: 111.
41. Cenac A., Simonoff M., Moretto P., Djibo A.: A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. International Journal of Cardiology 1992, 36: 57.
42. Fett J.D., Ansari A.A., Sundstrom J.B., Combs G.F.: Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. International Journal of Cardiology 2002, 86(2-3): 311-316.
43. Sanderson J.E., Adesanya C.O., Anjorin F.I., Parry E.H.: Postpartum cardiac failure – heart failure due to volume overload? American Heart Journal 1979, 97(5): 613-621.
44. Lee W.: Clinical management of gravid women with peripartum cardiomyopathy. Obstetrics and Gynecology Clinics of North America 1991, 18(2): 257-271.
45. Katz R., Karliner J.S., Resnik R.: Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978, 58(3 Pt 1): 434-441.
46. Manolio T., Baughman K.L., Rodeheffer R. et al.: Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute workshop). The American Journal of Cardiology 1992, 69: 1458.
47. Forster O., Hilfiker-Kleiner D., Ansari A.A., Sundstrom J.B., Libhaber E., Tshani W., Becker A., Yip A., Klein G., Sliwa K.: Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. European Journal of Heart Failure 2008, 10(9): 861-868.
48. Fett J.: The role of MRI in peripartum cardiomyopathy. International Journal of Cardiology 2009, 137: 185.
49. Baruteau A.E., Leurent G., Martins R.P., Thebault C., Treguer F., Leclercq C., Daubert J.C., Mabo P.: Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. International Journal of Cardiology 2010, 144(1): 143-145.
50. Leurent G., Baruteau A.E., Larralde A., Ollivier R., Schleich J.M., Boulmier D., Bedossa M., Langella B., Le Breton H.: Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. International Journal of Cardiology 2009, 132(3): e91-93.
51. Kawano H., Tsuneto A., Koide Y., Tasaki H., Sueyoshi E., Sakamoto I., Hayashi T.: Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Internal Medicine 2008, 47(2): 97-102.
52. Caballero-Borrego J., Garcia-Pinilla J.M., Rueda-Calle E., de Teresa-Galvan E.: [Evidence of gadolinium late-enhancement on cardiac magnetic resonance imaging in a patient with peripartum cardiomyopathy]. Revista Espanola de Cardiologia 2008, 61(2): 219-220.
53. Mouquet F., Lions C., de Groote P., Bouabdallaoui N., Willoteaux S., Dagorn J., Deruelle P., Lamblin N., Bauters C., Beregi J.P.: Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. European Radiology 2008, 18(12): 2765-2769.
54. Marmursztejn J., Vignaux O., Goffinet F., Cabanes L., Duboc D.: Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. International Journal of Cardiology 2009, 137(3): e63-64.
55. Barone-Rochette G., Rodiere M., Lantuejoul S.: Value of cardiac MRI in peripartum cardiomyopathy. Archives of Cardiovascular Diseases 2011, 104(4): 263-264.
56. Sliwa K., Hilfiker-Kleiner D., Petrie M.C., Mebazaa A., Pieske B., Buchmann E., Regitz-Zagrosek V., Schaufelberger M., Tavazzi L., van Veldhuisen D.J. et al.: Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure 2010, 12(8): 767-778.
57. Isezuo S.A., Abubakar S.A.: Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethnicity & Disease 2007, 17(2): 228-233.
58. Walsh J.J., Burch G.E., Black W.C., Ferrans V.J., Hibbs R.G.: Idiopathic Myocardiopathy of the Puerperium (Postpartal Heart Disease). Circulation 1965, 32: 19-31.
59. Mason J.W., O’Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., Moon T.E.: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 1995, 333(5): 269-275.
60. Bozkurt B., Villaneuva F.S., Holubkov R., Tokarczyk T., Alvarez R.J. Jr., MacGowan G.A., Murali S., Rosenblum W.D., Feldman A.M., McNamara D.M.: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. Journal of the American College of Cardiology 1999, 34(1): 177-180.
61. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J.P., Becker A., McMurray J., Yamac H., Labidi S., Struman I. et al.: Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010, 121(13): 1465-1473.
62. Hilfiker-Kleiner D., Meyer G.P., Schieffer E., Goldmann B., Podewski E., Struman I., Fischer P., Drexler H.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. Journal of the American College of Cardiology 2007, 50(24): 2354-2355.
63. Habedank D., Kuhnle Y., Elgeti T., Dudenhausen J.W., Haverkamp W., Dietz R.: Recovery from peripartum cardiomyopathy after treatment with bromocriptine. European Journal of Heart Failure 2008, 10(11): 1149-1151.
64. Elkayam U., Goland S.: Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation 2010, 121(13): 1463-1464.
65. Keogh A., Macdonald P., Spratt P., Marshman D., Larbalestier R., Kaan A.: Outcome in peripartum cardiomyopathy after heart transplantation. The Journal of Heart and Lung Transplantation 1994, 13(2): 202-207.
66. Felker G.M., Jaeger C.J., Klodas E., Thiemann D.R., Hare J.M., Hruban R.H., Kasper E.K., Baughman K.L.: Myocarditis and long-term survival in peripartum cardiomyopathy. American Heart Journal 2000, 140(5): 785-791.
67. Rickenbacher P.R., Rizeq M.N., Hunt S.A., Billingham M.E., Fowler M.B.: Long-term outcome after heart transplantation for peripartum cardiomyopathy. American Heart Journal 1994, 127(5): 1318-1323.
68. Zimmerman H., Bose R., Smith R., Copeland J.G.: Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. The Annals of Thoracic Surgery 2010, 89(4): 1211-1217.
69. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., Baughman K.L., Kasper E.K.: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 2000, 342(15): 1077-1084.
70. Ravikishore A.G., Kaul U.A., Sethi K.K., Khalilullah M.: Peripartum cardiomyopathy: prognostic variables at initial evaluation. International Journal of Cardiology 1991, 32(3): 377-380.
71. Witlin A.G., Mabie W.C., Sibai B.M.: Peripartum cardiomyopathy: an ominous diagnosis. American Journal of Obstetrics and Gynecology 1997, 176(1 Pt 1): 182-188.
72. Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., Lang R.M.: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. American Journal of Obstetrics and Gynecology 1997, 176(1 Pt 1): 189-195.
73. Amos A.M., Jaber W.A., Russell S.D.: Improved outcomes in peripartum cardiomyopathy with contemporary. American Heart Journal 2006, 152(3): 509-513.
74. Chapa J.B., Heiberger H.B., Weinert L., Decara J., Lang R.M., Hibbard J.U.: Prognostic value of echocardiography in peripartum cardiomyopathy. Obstetrics and Gynecology 2005, 105(6): 1303-1308.
75. Hu C.L., Li Y.B., Zou Y.G., Zhang J.M., Chen J.B., Liu J., Tang Y.H., Tang Q.Z., Huang C.X.: Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007, 93(4): 488-490.
76. Dorbala S., Brozena S., Zeb S., Galatro K., Homel P., Ren J.F., Chaudhry F.A.: Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. Journal of the American Society of Echocardiography 2005, 18(1): 45-48.
77. Goland S., Bitar F., Modi K., Safirstein J., Ro A., Mirocha J., Khatri N., Elkayam U.: Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. Journal of Cardiac Failure 2011, 17(5): 426-430.
78. Goland S., Modi K., Bitar F., Janmohamed M., Mirocha J.M., Czer L.S., Illum S., Hatamizadeh P., Elkayam U.: Clinical profile and predictors of complications in peripartum cardiomyopathy. Journal of Cardiac Failure 2009, 15(8): 645-650.
79. Elkayam U., Tummala P.P., Rao K., Akhter M.W., Karaalp I.S., Wani O.R., Hameed A., Gviazda I., Shotan A.: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med. 2001, 344(21): 1567-1571.
80. Sutton M.S., Cole P., Plappert M., Saltzman D., Goldhaber S.: Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. American Heart Journal 1991, 121(6 Pt 1): 1776-1778.
81. Sliwa K., Forster O., Zhanje F., Candy G., Kachope J., Essop R.: Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. The American Journal of Cardiology 2004, 93(11): 1441-1443, A1410.
82. Fett J.D., Christie L.G., Murphy J.G.: Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Annals of Internal Medicine 2006, 145(1): 30-34.